06Dec

[Comment] Alzheimer’s disease pathology in synucleinopathies

In a large clinicopathological correlative study in The Lancet Neurology, David J Irwin and colleagues1 investigate Alzheimer's disease pathology (ie, amyloid-β neuritic plaques and tau neurofibrillary tangles), α-synuclein Lewy body pathology, and other concomitant pathologies post-mortem in the brains of patients with clinically diagnosed synucleinopathies, which encompass dementia with Lewy bodies and Parkinson's disease dementia. Irwin and colleagues report that increased severity of Lewy body pathology and Alzheimer's disease pathology were associated with a shorter interval between onset of motor symptoms and onset of dementia and shorter disease duration.

Ander nieuws

20May

[Comment] A new step towards targeting tau

Progressive supranuclear palsy is a rare neurodegenerative disease characterised by an axial parkins...

naar nieuwsitem

20May

[Review] CSF and blood biomarkers for Parkinson’s disease

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urg...

naar nieuwsitem

22Apr

Parkinson’s disease patient: ‘I can walk… it’s really helped me’

Parkinson's disease patient Gail Jardine can walk more freely after having a spinal implant fit...

naar nieuwsitem